Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios

Authors

Karam Khaddour, Washington University School of Medicine in St. Louis
Alice Zhou, Washington University School of Medicine in St. Louis
Omar H Butt, Washington University School of Medicine in St. Louis
Griffin Budde, Natera, Inc
Allyson Koyen Malashevich, Natera, Inc
George Ansstas, Washington University School of Medicine in St. Louis

Journal

Frontiers in Oncology

Publication Date

1-1-2022

Volume

12

First Page

978996

Document Type

Open Access Publication

DOI

10.3389/fonc.2022.978996

Rights and Permissions

Khaddour K, Zhou A, Butt OH, Budde G, Malashevich AK and Ansstas G (2022) Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios. Front. Oncol. 12:978996. doi: 10.3389/fonc.2022.978996 © 2022 Khaddour, Zhou, Butt, Budde, Malashevich and Ansstas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Khaddour, Karam; Zhou, Alice; Butt, Omar H; Budde, Griffin; Malashevich, Allyson Koyen; and Ansstas, George, "Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios." Frontiers in Oncology. 12, 978996 (2022).
https://digitalcommons.wustl.edu/oa_4/2444

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.